Dr. Chakraborty is a physician certified by the Royal College in Medical Biochemistry and Pediatrics, with a subspecialty in Biochemical Genetics. He has a long history with the care of patients with Inherited Metabolic Diseases (IMD) and with leading population based Newborn Screening.  He started as a clinician seeing patients with IMD in 2003, and was the Medical and Laboratory Director for Newborn Screening Ontario (NSO) from 2007-2023; NSO leads the newborn screening program for the Province of Ontario which screens about 145,000 babies annually.  Since 2020, he has served as a Senior Medical Advisory for the Laboratories and Diagnostics Branch of the Ontario Ministry of Health, and co-chairs Ontario’s Provincial Genetics Advisory Committee.Throughout his career, he has been involved in clinical and translational research related to IEM. In addition to these roles, he became a Full Professor at the Faculty of Medicine in 2022, having been Associate Professor since 2014.

Dr. Chakraborty’s research interest focuses on the two areas of inherited metabolic diseases and newborn screening. He is involved in team research in newborn screening policy, the development of novel laboratory diagnostic and screening methods, translational metabolomics and disease pathophysiology research, as well as patient registries and observational outcome research. He has spoken at dozens of national and international panels and symposiums to share his expertise and discuss matters related to newborn screening. He has co-authored several chapters in books and 150 papers in peer-reviewed journals.

In 1990, Dr. Chakraborty graduated from the University of Toronto with a BSc in biochemistry with a minor in political science. In 1993, he completed the MD program at McMaster University. In 1998, he received a medical biochemistry degree from the University of Western Ontario (FRCPC). In 2000, he successfully completed pediatrics training at uOttawa (FRCPC). In 2002, he received a biochemical genetics degree from the University of Toronto (FCCMG).